Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucas Higuera

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Journal of Cardiac Failure|July 8, 2024
Association Between the Use of an Adaptive Cardiac Resynchronization Therapy Algorithm and Health Care Use and CostMichael R Gold, Jiani Zhou, Lucas Higuera, et al.
Plos One|June 24, 2022
Diagnostic sensitivity and cost per diagnosis of ambulatory cardiac monitoring strategies in unexplained syncope patientsJohn D Rogers, Lucas Higuera, Sarah C Rosemas, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 1, 2024
Two-year outcomes of Micra AV leadless pacemakers in the Micra AV CED studyMikhael F El-Chami, Lucas Higuera, Colleen Longacre, et al.
Journal of Cardiovascular Electrophysiology|February 22, 2023
Leadless versus transvenous single-chamber ventricular pacemakers: 3 year follow-up of the Micra CED studyGeorge H Crossley, Jonathan P Piccini, Colleen Longacre, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|February 9, 2023
Two-year outcomes of leadless vs. transvenous single-chamber ventricular pacemaker in high-risk subgroupsSerge Boveda, Lucas Higuera, Colleen Longacre, et al.
Plos One|November 19, 2020
Implantable cardioverter defibrillator therapy is cost effective for primary prevention patients in Taiwan: An analysis from the Improve SCA trialReece Holbrook, Lucas Higuera, Kael Wherry, et al.
Journal of Medical Economics|January 20, 2021
Comparison of cost-effectiveness of implantable cardioverter defibrillator therapy in patients for primary prevention in Latin America: an analysis using the Improve SCA studyLucas Higuera, Reece Holbrook, Kael Wherry, et al.
Heart Rhythm|September 24, 2023
Outcomes of patients implanted with an atrioventricular synchronous leadless ventricular pacemaker in the Medicare populationGeorge H Crossley, Colleen Longacre, Lucas Higuera, et al.
European Heart Journal|November 17, 2021
Leadless vs. transvenous single-chamber ventricular pacing in the Micra CED study: 2-year follow-upMikhael F El-Chami, Lindsay Bockstedt, Colleen Longacre, et al.
International Journal of Health Economics and Management|May 1, 2020
Patient and provider-level factors associated with changes in utilization of treatments in response to evidence on ineffectiveness or harmLaura Barrie Smith, Nihar R Desai, Bryan Dowd, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Journal of Cardiac Failure|July 8, 2024
Association Between the Use of an Adaptive Cardiac Resynchronization Therapy Algorithm and Health Care Use and CostMichael R Gold, Jiani Zhou, Lucas Higuera, et al.
Plos One|June 24, 2022
Diagnostic sensitivity and cost per diagnosis of ambulatory cardiac monitoring strategies in unexplained syncope patientsJohn D Rogers, Lucas Higuera, Sarah C Rosemas, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 1, 2024
Two-year outcomes of Micra AV leadless pacemakers in the Micra AV CED studyMikhael F El-Chami, Lucas Higuera, Colleen Longacre, et al.
Journal of Cardiovascular Electrophysiology|February 22, 2023
Leadless versus transvenous single-chamber ventricular pacemakers: 3 year follow-up of the Micra CED studyGeorge H Crossley, Jonathan P Piccini, Colleen Longacre, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|February 9, 2023
Two-year outcomes of leadless vs. transvenous single-chamber ventricular pacemaker in high-risk subgroupsSerge Boveda, Lucas Higuera, Colleen Longacre, et al.
Plos One|November 19, 2020
Implantable cardioverter defibrillator therapy is cost effective for primary prevention patients in Taiwan: An analysis from the Improve SCA trialReece Holbrook, Lucas Higuera, Kael Wherry, et al.
Journal of Medical Economics|January 20, 2021
Comparison of cost-effectiveness of implantable cardioverter defibrillator therapy in patients for primary prevention in Latin America: an analysis using the Improve SCA studyLucas Higuera, Reece Holbrook, Kael Wherry, et al.
Heart Rhythm|September 24, 2023
Outcomes of patients implanted with an atrioventricular synchronous leadless ventricular pacemaker in the Medicare populationGeorge H Crossley, Colleen Longacre, Lucas Higuera, et al.
European Heart Journal|November 17, 2021
Leadless vs. transvenous single-chamber ventricular pacing in the Micra CED study: 2-year follow-upMikhael F El-Chami, Lindsay Bockstedt, Colleen Longacre, et al.
International Journal of Health Economics and Management|May 1, 2020
Patient and provider-level factors associated with changes in utilization of treatments in response to evidence on ineffectiveness or harmLaura Barrie Smith, Nihar R Desai, Bryan Dowd, et al.
Pageof 3